They Saw it Coming
Our investors share a belief that the future of diabetes care will look nothing like the past, and they are helping make it real.
.png)
A venture capital and growth equity firm dedicated to partnering with entrepreneurs who seek to transform healthcare with breakthrough innovations in medical technology.
Winklevoss Capital. Backing determined builders working on hard problems in critical domains. Investing in builders on the frontier of technology and innovation.
A community-driven startup fund where founders, investors, and subject matter experts work together to find, evaluate, fund, and support the best companies.
Ascensia Diabetes Care, A global company entirely dedicated to improving the health and lives of people with diabetes. With over 80 years of history in diabetes management, their products are sold in over 100 countries worldwide.
Serpentine Ventures, A leading Swiss venture asset manager and the investment arm of Swiss Ventures Group. Supporting founders from pre-seed to Series B with capital, hands-on guidance, and strategic value.
.png)
Creating, growing, and investing in privately held, high-growth life science companies. Focused on diagnostic and therapeutic devices, biochemistry sensors, and innovative medical technologies.